Amy Schioldager - IShares Medical Executive Vice President
| IHI Etf | USD 60.69 0.04 0.07% |
Ms. Amy Schioldager serves as an Executive Vice President of Ishares Dow Jones US Medical Devices Index Fund since 2007. She is Managing Director, BTC Global Head of Index Equity, BGI Global Head of U.S. Indexing, BGI Head of Domestic Equity Portfolio Management, BGI .
| Age | 57 |
| Tenure | 17 years |
| Issuer | iShares |
| Inception Date | 2006-05-01 |
| Benchmark | Dow Jones U.S. Select Medical Equipment Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 4.92 Billion |
| Average Trading Valume | 478,081.5 |
| Asset Type | Equity |
| Category | Sector |
| Focus | Health Care |
| Market Concentration | Developed Markets |
Similar Fund Executives
| Showing other executives | One Year Return | ||
| Michael Latham | iShares Pharmaceuticals ETF | 53 | |
| Michael Latham | iShares Healthcare ETF | 53 | |
| Geoffrey Flynn | iShares Aerospace Defense | N/A | |
| Matt Tucker | iShares Aerospace Defense | N/A | |
| Michael Latham | iShares Expanded Tech Software | 53 | |
| Lee Sterne | iShares Aerospace Defense | 49 | |
| Geoffrey Flynn | iShares Expanded Tech Software | N/A | |
| Geoffrey Flynn | iShares Pharmaceuticals ETF | N/A | |
| Matt Tucker | iShares Expanded Tech Software | N/A | |
| Michael Latham | iShares Aerospace Defense | 53 | |
| Ira Shapiro | iShares Aerospace Defense | 51 | |
| Ira Shapiro | iShares Healthcare ETF | 51 | |
| Matt Tucker | iShares Pharmaceuticals ETF | N/A | |
| Ira Shapiro | iShares Expanded Tech Software | 51 | |
| Matt Tucker | iShares Healthcare ETF | N/A | |
| Geoffrey Flynn | iShares Healthcare ETF | N/A | |
| Ira Shapiro | iShares Pharmaceuticals ETF | 51 | |
| Patrick OConnor | iShares Aerospace Defense | 48 | |
iShares Medical Devices Money Managers
| Geoffrey Flynn, Chief Operating Officer, Executive Vice President | ||
| Robert Silver, Independent Trustee | ||
| John Kerrigan, Independent Trustee | ||
| Madhav Rajan, Independent Trustee | ||
| Matt Tucker, Vice President | ||
| Cecilia Herbert, Independent Trustee | ||
| Michael Latham, President Trustee | ||
| Jack Gee, Chief Financial Officer, Treasurer | ||
| Charles Hurty, Independent Trustee | ||
| Eilleen Clavere, Secretary | ||
| George Parker, Independent Chairman of the Board of Trustees | ||
| John Martinez, Independent Trustee | ||
| Amy Schioldager, Executive Vice President | ||
| Robert Kapito, Trustee | ||
| Ira Shapiro, Vice President Chief Legal Officer |
IShares Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is IShares Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Price To Earning | 24.14 X | |||
| Price To Book | 3.03 X | |||
| Price To Sales | 3.38 X | |||
| Number Of Employees | 15 | |||
| Beta | 1.04 | |||
| Total Asset | 5.79 B | |||
| One Year Return | 21.30 % | |||
| Three Year Return | (1.40) % | |||
| Five Year Return | 7.70 % | |||
| Ten Year Return | 13.10 % |
Currently Active Assets on Macroaxis
When determining whether iShares Medical Devices offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IShares Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ishares Medical Devices Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ishares Medical Devices Etf:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Medical Devices. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
The market value of iShares Medical Devices is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Medical's value that differs from its market value or its book value, called intrinsic value, which is IShares Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Medical's market value can be influenced by many factors that don't directly affect IShares Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.